(PharmaNewsWire.Com, January 11, 2017 ) The Lung Cancer Therapeutics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc.
Lung cancer is a malignant lung carcinoma which is characterized by irregular cell growth in lung tissue. As the tumour grows in size, it reduces the lungs ability to provide oxygen to arteries, veins and capillaries. It is the common cause of mortality and illness not only in developed countries but also in developing countries. Smoking is thought as a main cause of lung cancer, though lung cancer also follows in non-smokers.
Air pollution, amplified alcohol consumption, varying life style, smoking, unhealthy food, and no physical activity are the factors indirectly driving the market. Governments in the developing economies are providing awareness among the people about the cancer. As the geriatric population is likely to increase, the incidence of lung cancer is predicted to rise, thus acting as a driver for revenue growth.
The prominent players of this market include BoehringerIngelheim GmbH, Hoffman-La Roche, Pfizer Inc., GlaxoSmitKline, Eli Lilly and Company, Agennix AG, AstrazenecaPlc and Sanofi-Aventis.
About us: Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
